In the cancer-induced pain model used in this study, it was reported that bradykinin and related peptides released from melanoma cells might cause spontaneous pain and allodynia [29]; however, we identified that the enhancement of IL-1β production, which may be predominantly released from immune cells invading tissues surrounding tumours, is another potential factor for causing pain. This evidence concerns the gene IL1B and cancer.